- Home
- KNSA vs HE Comparison
KNSA vs HE Comparison
Compare KNSA & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- HE
- Stock Information
- Founded
- KNSA 2015
- HE 1891
- Country
- KNSA United Kingdom
- HE United States
- Employees
- KNSA N/A
- HE N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- HE Electric Utilities: Central
- Sector
- KNSA Health Care
- HE Utilities
- Exchange
- KNSA Nasdaq
- HE Nasdaq
- Market Cap
- KNSA 1.6B
- HE N/A
- IPO Year
- KNSA 2018
- HE N/A
- Fundamental
- Price
- KNSA $22.52
- HE $10.84
- Analyst Decision
- KNSA Strong Buy
- HE Hold
- Analyst Count
- KNSA 6
- HE 4
- Target Price
- KNSA $37.17
- HE $11.00
- AVG Volume (30 Days)
- KNSA 684.1K
- HE 2.7M
- Earning Date
- KNSA 04-22-2025
- HE 05-09-2025
- Dividend Yield
- KNSA N/A
- HE N/A
- EPS Growth
- KNSA N/A
- HE N/A
- EPS
- KNSA N/A
- HE N/A
- Revenue
- KNSA $423,239,000.00
- HE $3,219,850,000.00
- Revenue This Year
- KNSA $37.21
- HE $13.45
- Revenue Next Year
- KNSA $1.38
- HE $1.70
- P/E Ratio
- KNSA N/A
- HE N/A
- Revenue Growth
- KNSA 56.60
- HE N/A
- 52 Week Low
- KNSA $16.56
- HE $7.61
- 52 Week High
- KNSA $28.15
- HE $18.19
- Technical
- Relative Strength Index (RSI)
- KNSA 60.12
- HE 56.09
- Support Level
- KNSA $22.62
- HE $10.88
- Resistance Level
- KNSA $23.42
- HE $11.29
- Average True Range (ATR)
- KNSA 0.75
- HE 0.37
- MACD
- KNSA -0.01
- HE -0.04
- Stochastic Oscillator
- KNSA 68.88
- HE 48.17
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.